New long idea
$axsm stock will not remain depressed for long!
$AXSM: This stock will not remain depressed for long!
Biotech is tough even for those with medical backgrounds. At my first hedge fund, we had a seasoned doctor with biotech experience who couldn’t pick stocks for his life. I try and generally skip anything binary and wait for mispriced situations based on de-risked, already approved drugs. $AXSM is incredibly interesting with the potential for a takeout 3-5x the current price or large appreciation over time based on the approved, and now in the market as of last week, drug Auvelity to treat major depressive disorder plus many other shots on goal (see below). The headline here is the Auvelity is the first oral new drug for MDD approved by the FDA in the last 60 years. If that doesn’t raise an eyebrow for you as an investor then nothing will! See our thesis below.